BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 18237719)

  • 1. An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides.
    Tatai J; Osztrovszky G; Kajtár-Peredy M; Fügedi P
    Carbohydr Res; 2008 Mar; 343(4):596-606. PubMed ID: 18237719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Approaches to L-Iduronic Acid and L-Idose: Key Building Blocks for the Preparation of Glycosaminoglycan Oligosaccharides.
    Mohamed S; Ferro V
    Adv Carbohydr Chem Biochem; 2015; 72():21-61. PubMed ID: 26613814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Heparan Sulfate- and Dermatan Sulfate-Related Oligosaccharides via Iterative Chemoselective Glycosylation Exploiting Conformationally Disarmed [2.2.2] l-Iduronic Lactone Thioglycosides.
    Jeanneret RA; Dalton CE; Gardiner JM
    J Org Chem; 2019 Dec; 84(23):15063-15078. PubMed ID: 31674785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo synthesis of uronic acid building blocks for assembly of heparin oligosaccharides.
    Adibekian A; Bindschädler P; Timmer MS; Noti C; Schützenmeister N; Seeberger PH
    Chemistry; 2007; 13(16):4510-22. PubMed ID: 17444537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel efficient routes to heparin monosaccharides and disaccharides achieved via regio- and stereoselective glycosidation.
    Yu HN; Furukawa J; Ikeda T; Wong CH
    Org Lett; 2004 Mar; 6(5):723-6. PubMed ID: 14986959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of fully and partially protected fucosyl donors for oligosaccharide synthesis.
    Daly R; McCabe T; Scanlan EM
    J Org Chem; 2013 Feb; 78(3):1080-90. PubMed ID: 23268556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of L-iduronic acid derivatives via [3.2.1] and [2.2.2] L-iduronic lactones from bulk glucose-derived cyanohydrin hydrolysis: a reversible conformationally switched superdisarmed/rearmed lactone route to heparin disaccharides.
    Hansen SU; Dalton CE; Baráth M; Kwan G; Raftery J; Jayson GC; Miller GJ; Gardiner JM
    J Org Chem; 2015 Apr; 80(8):3777-89. PubMed ID: 25646641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the solid-phase synthesis of heparan sulfate oligosaccharides: evaluation of iduronic acid and idose building blocks.
    Guedes N; Czechura P; Echeverria B; Ruiz A; Michelena O; Martin-Lomas M; Reichardt NC
    J Org Chem; 2013 Jul; 78(14):6911-34. PubMed ID: 23786303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides.
    Polat T; Wong CH
    J Am Chem Soc; 2007 Oct; 129(42):12795-800. PubMed ID: 17914818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of silyl protections on the anomeric reactivity of galactofuranosyl thioglycosides and application of the silylated thiogalactofuranosides to one-pot synthesis of diverse β-D-oligogalactofuranosides.
    Wang S; Meng X; Huang W; Yang JS
    J Org Chem; 2014 Nov; 79(21):10203-17. PubMed ID: 25310684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective 1,2-cis glycosylation of 2-O-allyl protected thioglycosides.
    Aloui M; Chambers DJ; Cumpstey I; Fairbanks AJ; Redgrave AJ; Seward CM
    Chemistry; 2002 Jun; 8(11):2608-21. PubMed ID: 12180341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and scalable conversion of L-iduronamides to heparin-related di- and tetrasaccharides.
    Hansen SU; Miller GJ; Baráth M; Broberg KR; Avizienyte E; Helliwell M; Raftery J; Jayson GC; Gardiner JM
    J Org Chem; 2012 Sep; 77(18):7823-43. PubMed ID: 22900939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo synthesis of differentially protected L-iduronic acid glycosylating agents.
    Bindschädler P; Adibekian A; Grünstein D; Seeberger PH
    Carbohydr Res; 2010 May; 345(7):948-55. PubMed ID: 20193949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modular synthesis of heparin oligosaccharides.
    Orgueira HA; Bartolozzi A; Schell P; Litjens RE; Palmacci ER; Seeberger PH
    Chemistry; 2003 Jan; 9(1):140-69. PubMed ID: 12506372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy.
    Codée JD; Stubba B; Schiattarella M; Overkleeft HS; van Boeckel CA; van Boom JH; van der Marel GA
    J Am Chem Soc; 2005 Mar; 127(11):3767-73. PubMed ID: 15771511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a bicyclic analog of L-iduronic acid adopting the biologically relevant 2S0 conformation.
    Herrera AJ; Beneitez MT; Amorim L; Cañada FJ; Jiménez-Barbero J; Sinaÿ P; Blériot Y
    Carbohydr Res; 2007 Sep; 342(12-13):1876-87. PubMed ID: 17359949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis.
    Demeter F; Gyöngyösi T; Bereczky Z; Kövér KE; Herczeg M; Borbás A
    Sci Rep; 2018 Sep; 8(1):13736. PubMed ID: 30213971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depiction of the forces participating in the 2-O-sulfo-alpha-L-iduronic acid conformational preference in heparin sequences in aqueous solutions.
    Pol-Fachin L; Verli H
    Carbohydr Res; 2008 Jul; 343(9):1435-45. PubMed ID: 18452898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward synthesis of the regular sequence of heparin: synthesis of two tetrasaccharide precursors.
    Zhou Y; Lin F; Chen J; Yu B
    Carbohydr Res; 2006 Jul; 341(10):1619-29. PubMed ID: 16529732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. d-Idose, d-Iduronic Acid, and d-Idonic Acid from d-Glucose via Seven-Carbon Sugars.
    Liu Z; Jenkinson SF; Yoshihara A; Wormald MR; Izumori K; Fleet GWJ
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31635397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.